Asher Chanan‐Khan

21.6k citations
368 papers · 10.9k · 3 hit papers · h-index 50

Impact in

  • Hematology top 0.05%
    • Multiple Myeloma Research and Treatments
  • Genetics top 0.1%
    • Chronic Lymphocytic Leukemia Research

Papers in

    • Multiple Myeloma Research and Treatments 164
    • Chronic Lymphocytic Leukemia Research 157

Asher Chanan‐Khan

353 papers receiving 10.6k citations

Asher Chanan‐Khan's Hit Papers

Daratumumab, Bortezomib, and Dexamethasone for Multiple Myeloma 2016 · 1.1k citations
1.1k0+6+12Years since publication2505007501000

Peers

Asher Chanan‐Khan
Comparison fields: 5 of 145
  • Hematology 5.3k
  • Genetics 2.6k
  • Oncology 3.4k
  • Pathology and Forensic Medicine 1.8k
  • Immunology 1.4k
Replace Irene M. Ghobrial with:
Irene M. Ghobrial United States
Varsha Gandhi United States
Robert Z. Orlowski United States
Andrew R. Belch Canada
Daniel J. DeAngelo United States
Xavier Leleu France
Jonathan E. Kolitz United States
Hervé Dombret France
Ravi Vij United States
Alan F. List United States
Asher Chanan‐Khan relative to Irene M. Ghobrial United States Irene M. Ghobrial's profile →
Citations per field
00.5×1.5×
Irene M. Ghobrial · 1×
Citations per year

Countries citing papers authored by Asher Chanan‐Khan

Since Specialization
Citations

This map shows the geographic impact of Asher Chanan‐Khan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Asher Chanan‐Khan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Asher Chanan‐Khan more than expected).

Fields of papers citing papers by Asher Chanan‐Khan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Asher Chanan‐Khan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Asher Chanan‐Khan. The network helps show where Asher Chanan‐Khan may publish in the future.

Co-authors

The 25 scholars most cited alongside Asher Chanan‐Khan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Asher Chanan‐Khan Line = papers co-authored together Asher Chanan‐Khan links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 368 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Daratumumab, Bortezomib, and Dexamethasone for Multiple Myeloma
Hit paper breakdown →
20161065
2
Lenalidomide plus Dexamethasone for Relapsed Multiple Myeloma in North America
Hit paper breakdown →
2007928
3
Potent activity of carfilzomib, a novel, irreversible inhibitor of the ubiquitin-proteasome pathway, against preclinical models of multiple myeloma
Hit paper breakdown →
2007592
4 2003376
5 2006314
6 2007218
7 2017205
8 2009202
9 2008196
10 2006190
11 2002173
12 2012171
13 2011140
14 2010137
15 2008132
16 2009126
17 2011111
18 2005111
19 2013105
20 201696

About Asher Chanan‐Khan

Asher Chanan‐Khan is a scholar working on Hematology, Genetics, Molecular Biology, Oncology and Pathology and Forensic Medicine, having authored 368 papers that have together received 10.9k indexed citations. Recurring topics across this work include Multiple Myeloma Research and Treatments (164 papers), Chronic Lymphocytic Leukemia Research (157 papers), Lymphoma Diagnosis and Treatment (72 papers), Protein Degradation and Inhibitors (64 papers), Cancer Treatment and Pharmacology (39 papers), Peptidase Inhibition and Analysis (37 papers), Monoclonal and Polyclonal Antibodies Research (24 papers) and Acute Lymphoblastic Leukemia research (24 papers). The work is most often cited by research in Hematology (5.3k citations), Genetics (2.6k citations), Oncology (3.4k citations), Pathology and Forensic Medicine (1.8k citations) and Immunology (1.4k citations). Asher Chanan‐Khan has collaborated with scholars based in United States, Germany and Australia. Frequent co-authors include Sagar Lonial, Sikander Ailawadhi, Kena C. Miller, Aneel Paulus, Paul G. Richardson, Kenneth C. Anderson, Taimur Sher, Edward A. Stadtmauer, S. Vincent Rajkumar and Myron S. Czuczman. Their work appears in journals such as Blood, Journal of Clinical Oncology, British Journal of Haematology, Blood Cancer Journal and Cancer.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact